Profound Medical Corp is experiencing a significant drop in its stock value, which has raised concerns among investors.
In the latest trading session, Profound Medical Corp (PRN.TO) saw its stock price fall by 4.39%, closing at CA$9.14. This decline comes despite the company’s recent announcements of strong financial results, leaving investors wondering about the reasons behind this downturn.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeMarket cap
$365.19M
52W high
$12.40
52W low
$5.23
1W change
-2.87%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 146.4% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+146.4% Upside
Current Price
C$10.16
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
42.5%
Annualized
90-Day Vol
82.2%
Annualized
Trend (90d)
+45.4%
Annualized drift
90d Mean
C$11.95
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.72 | C$9.26 – C$12.42 |
| 60 trading days | C$11.32 | C$9.20 – C$13.93 |
| 90 trading days | C$11.95 | C$9.26 – C$15.41 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Although Profound Medical Corp has reported impressive revenue growth recently, the current slide in stock price suggests there may be underlying issues that investors should keep an eye on.
Stock slides 4.39% in one day
Profound Medical Corp's market cap now stands at CA$339.39 million, highlighting the volatility often seen in small-cap stocks.
Bull case
Profound Medical reported an 87% year-over-year revenue increase, reaching CA$5.3 million in Q3 2025. This showcases the company's potential for growth and profitability in the medical technology sector.
Bear case
Despite the strong revenue growth, the recent performance of the stock reflects investor skepticism. This could be due to broader market trends or concerns about the company's long-term profitability, especially given its negative profit margin.
Recent Performance Overview
Today, Profound Medical Corp's stock performance shows a notable decline, closing down 4.39%. This downturn raises questions about investor sentiment, particularly in light of the company’s recent announcements of strong financial results, including a significant revenue increase in Q3 2025.
Market Sentiment and Future Outlook
Even with impressive revenue growth reported by Profound Medical, the stock's decline suggests that investors may be cautious about the company's long-term viability. With a profit margin currently at -2.07%, concerns about profitability could be heavily influencing investor decisions. As the company prepares for upcoming presentations and potential fundraising efforts, the market will be closely watching how these developments unfold.
Advertisement
